|
- Medical Management - Duchenne Muscular Dystrophy (DMD)
The categories of medications for DMD include corticosteroids, gene therapy, exon skipping drugs, and therapies that promote growth and regeneration A number of drugs have been approved by the FDA to treat DMD over the last decade
- New Resource! Safe Unsafe Medications in Duchenne
Many years ago, PPMD developed a one-page resource of safe and unsafe medications in Duchenne While many of those medications are now discussed in various related sections of our website, we recognize the need for an updated, downloadable resource that summarizes both old and new medications
- Anti Inflammatory Drugs - TREAT-NMD
By suppressing the immune system with corticosteroids, muscle damage will be less severe and less scar tissue will be formed Corticosteroids delay Duchenne disease progression and therefore they are part of the standards of care for DMD even though chronic use is associated with side effects
- Cardioprotective medication in Duchenne muscular dystrophy: a single . . .
We investigated the effects of cardioprotective medications [angiotensin-converting enzyme inhibitors (ACE-I), beta-blockers] on clinical outcomes in DMD patients
- Duchenne Muscular Dystrophy Treatment: A Support Guide
Therapeutic interventions for treating DMD include treatments to help slow down muscle degeneration and medications to help alleviate the effects of DMD on the heart Additionally, supportive equipment can help manage the effects of DMD on movement, breathing, swallowing, and the digestive system
- Duchenne Muscular Dystrophy Treatment - raredisease. net
One of the main treatments for DMD is steroid drugs (corticosteroids) Steroids are commonly prescribed to people with DMD to help slow the progression of muscle weakness They help reduce the risk of scoliosis (curving of the spine) and delay heart problems These are common complications of DMD
- Current Pharmacological Strategies for Duchenne Muscular Dystrophy
There is still no cure for DMD so far and the standard of care is principally limited to symptom relief through glucocorticoids treatments Current therapeutic strategies could be divided into two lines
|
|
|